Kicking the 'counterfeit' out of fake drugs: IOM panel calls for mandatory track-and-trace system in US
This article was originally published in SRA
Executive Summary
One of the greatest roadblocks standing in the way of countering the problem of falsified and substandard drugs is the use of the term "counterfeit", argues a US Institute of Medicine panel, which has called for the creation by the Food and Drug Administration of a mandatory track-and-trace system 1.